22080567
Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer.
SupplementaryTableS2andFig.2A
Homo sapiens
9606
serum
Nuclear Magnetic Resonance
colorectal cancer
DOID:9256
Glycerol
HMDB00131
Increased
0.05
nonparametric Kruskal-Wallis test
Cancer Res
2012 Jan 1
Bertini I,Cacciatore S,Jensen BV,Schou JV,Johansen JS,Kruhffer M,Luchinat C,Nielsen DL,Turano P
